GI Bleed in a Hemodialysis Patient with Calciphylaxis and Paroxysmal Atrial Fibrillation: Should Warfarin therapy be continued?
Calciphylaxis is a late complication of end-stage renal disease (ESRD) affecting ~1–4% patients on hemodialysis, with a mortality rate of >50%. Cutaneous manifestations include necrotic, non-healing ulcers most commonly in the lower extremities. Visceral organ vasculopathy often occurs as well. W...
Main Authors: | Bowles, Alicia, Trofimovitch, Diana, MD, Treece, Jennifer, MD |
---|---|
Format: | Others |
Published: |
Digital Commons @ East Tennessee State University
2018
|
Subjects: | |
Online Access: | https://dc.etsu.edu/asrf/2018/schedule/147 |
Similar Items
-
Penile calciphylaxis: A severe case managed with partial penectomy
by: Kerry Adler, et al.
Published: (2021-01-01) -
Warfarin and the Risk of Death, Stroke, and Major Bleeding in Patients With Atrial Fibrillation Receiving Hemodialysis: A Systematic Review and Meta-Analysis
by: Hong Lei, et al.
Published: (2018-11-01) -
An unusual case of calciphylaxis in a psoriatic patient without kidney disease
by: Maria Mihailescu, BS, et al.
Published: (2021-04-01) -
Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis
by: Jee Eun Park, et al.
Published: (2016-03-01) -
Calciphylaxis of the breast, mimicking advanced breast cancer with skin involvement
by: Joseph T. George, B.S., et al.
Published: (2021-05-01)